Libros importados hasta 50% OFF + Envío Gratis a todo USA  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway (in English)
Type
Physical Book
Publisher
Language
Inglés
Pages
50
Format
Paperback
Dimensions
22.9 x 15.2 x 0.3 cm
Weight
0.10 kg.
ISBN13
9781636484167

Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway (in English)

Shiva Prasad Kollur (Author) · Eliva Press · Paperback

Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway (in English) - Kollur, Shiva Prasad

Physical Book

$ 34.00

$ 42.50

You save: $ 8.50

20% discount
  • Condition: New
It will be shipped from our warehouse between Friday, July 05 and Monday, July 08.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "Drug Repurposing Approach for Non-Small Cell Lung Cancer Targeting MAPK Signaling Pathway (in English)"

Non-small cell lung cancer (NSCLC) is a prominent subtype of lung carcinoma that accounts for the majority of cancer-related deaths globally, and it is responsible for about 80% to 85% of lung cancers. Mitogen-Activated Protein Kinase (MAPK) signaling pathways are a vital aspect of NSCLC, and have aided in the advancement of therapies for this carcinoma. Targeting the Ras/Raf/MEK/ERK pathway is a promising and alternative method in NSCLC treatment, which is highlighted in this book. The introduction of targeted medicines has revolutionized the treatment of patients with this carcinoma. When combined with current systems biology-driven stratagems, repurposing non-cancer drugs into new therapeutic niches presents a cost-effective and efficient technique with enhancing outcomes for discovering novel pharmacological activity. This book also highlights the successful cutting-edge techniques while focusing on NSCLC targeted therapies. The ultimate challenge will be integrating these repurposed drugs into the therapeutic regimen of patients affected with NSCLC to potentially increase lung cancer cure rates. Authors: Shiva Prasad Kollur, Anisha S Jain, Gayatri Vaidya, Poojitha B. Sridara Setty, Shivalingaiah, Ashwini Prasad, Ravindra Veerapur, Veena Malligere Ankegowda, Asad Syed, Ali. H Bhakali, Chandrashekar Srinivasa, Sharanagouda Patil, Chandan Shivamallu

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews